Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul;132(7):77007.
doi: 10.1289/EHP13667. Epub 2024 Jul 24.

Investigation of Peroxisome Proliferator-Activated Receptor Genes as Requirements for Visual Startle Response Hyperactivity in Larval Zebrafish Exposed to Structurally Similar Per- and Polyfluoroalkyl Substances (PFAS)

Affiliations

Investigation of Peroxisome Proliferator-Activated Receptor Genes as Requirements for Visual Startle Response Hyperactivity in Larval Zebrafish Exposed to Structurally Similar Per- and Polyfluoroalkyl Substances (PFAS)

Sebastian Gutsfeld et al. Environ Health Perspect. 2024 Jul.

Abstract

Background: Per- and polyfluoroalkyl Substances (PFAS) are synthetic chemicals widely detected in humans and the environment. Exposure to perfluorooctanesulfonic acid (PFOS) or perfluorohexanesulfonic acid (PFHxS) was previously shown to cause dark-phase hyperactivity in larval zebrafish.

Objectives: The objective of this study was to elucidate the mechanism by which PFOS or PFHxS exposure caused hyperactivity in larval zebrafish.

Methods: Swimming behavior was assessed in 5-d postfertilization (dpf) larvae following developmental (1-4 dpf) or acute (5 dpf) exposure to 0.43-7.86μM PFOS, 7.87-120μM PFHxS, or 0.4% dimethyl sulfoxide (DMSO). After developmental exposure and chemical washout at 4 dpf, behavior was also assessed at 5-8 dpf. RNA sequencing was used to identify differences in global gene expression to perform transcriptomic benchmark concentration-response (BMCT) modeling, and predict upstream regulators in PFOS- or PFHxS-exposed larvae. CRISPR/Cas9-based gene editing was used to knockdown peroxisome proliferator-activated receptors (ppars) pparaa/ab, pparda/db, or pparg at day 0. Knockdown crispants were exposed to 7.86μM PFOS or 0.4% DMSO from 1-4 dpf and behavior was assessed at 5 dpf. Coexposure with the ppard antagonist GSK3787 and PFOS was also performed.

Results: Transient dark-phase hyperactivity occurred following developmental or acute exposure to PFOS or PFHxS, relative to the DMSO control. In contrast, visual startle response (VSR) hyperactivity only occurred following developmental exposure and was irreversible up to 8 dpf. Similar global transcriptomic profiles, BMCT estimates, and enriched functions were observed in PFOS- and PFHxS-exposed larvae, and ppars were identified as putative upstream regulators. Knockdown of pparda/db, but not pparaa/ab or pparg, blunted PFOS-dependent VSR hyperactivity to control levels. This finding was confirmed via antagonism of ppard in PFOS-exposed larvae.

Discussion: This work identifies a novel adverse outcome pathway for VSR hyperactivity in larval zebrafish. We demonstrate that developmental, but not acute, exposure to PFOS triggered persistent VSR hyperactivity that required ppard function. https://doi.org/10.1289/EHP13667.

PubMed Disclaimer

Figures

Figures 1A and 1D are each a single graph showing six endpoints titled Light phase 1, Light phase 2, Dark phase 1, and Dark phase 2, plotting Distance moved, Visual startle response 1 (VSR1) and Visual startle response 2 (centimeters per second), ranging from 0.0 to 0.5 in increments of 0.1 (y-axis) across time (seconds), ranging from 1,200 to 3,600 in increments of 600 (x-axis) for 7.86 Perfluorooctanesulfonic acid (micromolar) and 0.4 percent Dimethyl sulfoxide; and 120 Perfluorohexanesulfonic acid (micromolar) and 0.4 percent Dimethyl sulfoxide, respectively. Figures 1B and 1E are each a set of four violin plots titled Light phase 1 (L1), Light phase 2 (L2), Dark phase 1 (D1), and Dark phase 2 (D2), plotting Summed distance moved (centimeters per 2 minutes), ranging from 0 to 30 in increments of 10; 0 to 30 in increments of 10; 0 to 60 in increments of 20; and 0 to 60 in increments of 20 (y-axis) across Perfluorooctanesulfonic acid (micromolar), ranging from 0.4 percent Dimethyl sulfoxide, 0.43 to 0.77 in increments of 0.34, 0.77 to 1.38 in increments of 0.61, 1.38 to 2.47 in increments of 1.09, 2.47 to 4.06 in increments of 1.59, 4.06 to 7.86 in increments of 3.8; and Perfluorohexanesulfonic acid (micromolar), ranging from 0.4 percent Dimethyl sulfoxide, 7.87 to 14.05 in increments of 6.18, 14.05 to 25.09 in increments of 11.04, 25.09 to 44.8 in increments of 19.72, 44.8 to 80 in increments of 35.2, and 80 to 120 in increments of 40 (x-axis), respectively. Figures 1C and 1F are each a set of two violin plots titled VSR1 and VSR2, plotting Summed distance moved (centimeters per 3 seconds), ranging from 0 to 4 in unit increments (y-axis) across Perfluorooctanesulfonic acid (micromolar), ranging from 0.4 percent Dimethyl sulfoxide, 0.43 to 0.77 in increments of 0.34, 0.77 to 1.38 in increments of 0.61, 1.38 to 2.47 in increments of 1.09, 2.47 to 4.06 in increments of 1.59, 4.06 to 7.86 in increments of 3.8; and Perfluorohexanesulfonic acid (micromolar), ranging from 0.4 percent Dimethyl sulfoxide, 7.87 to 14.05 in increments of 6.18, 14.05 to 25.09 in increments of 11.04, 25.09 to 44.8 in increments of 19.72, 44.8 to 80 in increments of 35.2, and 80 to 120 in increments of 40 (x-axis) for Perfluorooctanesulfonic acid (micromolar), including 0.4 percent Dimethyl sulfoxide with 43 cases, 0.43 micromolar with 20 cases, 0.77 micromolar with 22 cases, 1.38 micromolar with 20 cases, 2.47 micromolar with 20 cases, 4.06 micromolar with 19 cases, and 7.86 micromolar with 18 cases; and Perfluorohexanesulfonic acid (micromolar), including 0.4 percent Dimethyl sulfoxide with 42 cases, 7.87 micromolar with 23 cases, 14.05 micromolar with 20 cases, 25.09 micromolar with 22 cases, 44.8 micromolar with 21 cases, 80 micromolar with 22 cases, and 120 micromolar with 15 cases, respectively.
Figure 1.
Locomotor activity assessment in 5-dpf zebrafish developmentally exposed to PFOS or PFHxS. Locomotor response following exposure to (A) 7.86μM PFOS (blue), (D) 120μM PFHxS (green), or 0.4% DMSO (gray) in the light (yellow)–dark (white) transition test. Data expressed as the mean distance moved (cm/s) ± standard error and represent 15–43 larvae per group. (B,E) Distance moved (cm) for each larva in 2-min periods across each 10-min light phase at 13,238 lux (L1, L2) and dark phase at 0 lux (D1, D2). Data are represented as box and violin plots. Violins around the box plots describe the kernel probability density of the underlying data. Significance was determined by Tukey-adjusted estimated marginal means following a generalized additive mixed effects model. Significant differences (p<0.05) between groups are indicated by different letters. VSR data [within 3 s after dark–light (VSR1) or light–dark transition (VSR2)] following developmental exposure to (C) 0.437.86μM PFOS, or (F) 7.87120μM PFHxS are also shown. Data are represented as box and violin plots and comprise 1 value per larva for VSR1 and VSR2. Significance was determined by Tukey-adjusted estimated marginal means following a linear mixed effects model. Significant differences (p<0.05) between groups are indicated by different letters. Individual box plots comprise a box that describes the IQR, a bold line that represents the median, and whiskers that indicate the calculated minimum (25th percentile 1.5× IQR) and the calculated maximum (75th percentile +1.5× IQR). Dots represent outliers beyond the calculated minima or maxima. Violins around the box plots describe the kernel probability density of the underlying data. Replicate numbers tested for PFOS ranged from 18 to 43 larvae (C) and from 15 to 42 larvae for PFHxS (F). Summary data can be found in Excel Tables S1–S4. Note: D, dark; DMSO, dimethyl sulfoxide; dpf, days postfertilization; IQR, interquartile range; L, light; PFHxS, perfluorohexanesulfonic acid; PFOS, perfluorooctanesulfonic acid; VSR, visual startle response.
Figures 2A and 2D are each a single graph showing six endpoints titled Light phase 1, Light phase 2, Dark phase 1, and Dark phase 2, plotting Distance moved (centimeters per second), ranging from 0.0 to 0.5 in increments of 0.1 (y-axis) across time (seconds), ranging from 1,200 to 3,600 in increments of 600 (x-axis) for 7.86 Perfluorooctanesulfonic acid (micromolar) and 0.4 percent Dimethyl sulfoxide; and 146.4 Perfluorohexanesulfonic acid (micromolar) and 0.4 percent Dimethyl sulfoxide, respectively. Figures 2B and 2E are each a set of four violin plots titled Light phase 1 (L1), Light phase 2 (L2), Dark phase 1 (D1), and Dark phase 2 (D2), plotting Summed distance moved (centimeters per 2 minutes), ranging from 0 to 30 in increments of 10; 0 to 30 in increments of 10; 0 to 60 in increments of 20; and 0 to 60 in increments of 20 (y-axis) across Perfluorooctanesulfonic acid (micromolar), ranging from 0.4 percent Dimethyl sulfoxide, 0.43 to 0.77 in increments of 0.34, 0.77 to 1.38 in increments of 0.61, 1.38 to 2.48 in increments of 1.1, 2.48 to 4.4 in increments of 1.92, 4.4 to 7.86 in increments of 3.46; and Perfluorohexanesulfonic acid (micromolar), ranging from 0.4 percent Dimethyl sulfoxide, 44.8 to 80 in increments of 35.2, 80 to 120 in increments of 40, 120 to 133.2 in increments of 13.2, 133.2 to 146.4 in increments of 13.2, and 146.4 to 160 in increments of 13.6 (x-axis), respectively. Figures 2C and 2F are each a set of two violin plots titled VSR1 and VSR2, plotting Summed distance moved (centimeters per 3 seconds), ranging from 0 to 3 in unit increments (y-axis) across Perfluorooctanesulfonic acid (micromolar), ranging from 0.4 percent Dimethyl sulfoxide, 0.43 to 0.77 in increments of 0.34, 0.77 to 1.38 in increments of 0.61, 1.38 to 2.48 in increments of 1.1, 2.48 to 4.4 in increments of 1.92, 4.4 to 7.86 in increments of 3.46; and Perfluorohexanesulfonic acid (micromolar), ranging from 0.4 percent Dimethyl sulfoxide, 44.8 to 80 in increments of 35.2, 80 to 120 in increments of 40, 120 to 133.2 in increments of 13.2, 133.2 to 146.4 in increments of 13.2, and 146.4 to 160 in increments of 13.6 (x-axis) for Perfluorooctanesulfonic acid (micromolar), including 0.4 percent Dimethyl sulfoxide with 47 cases, 0.43 micromolar with 24 cases, 0.77 micromolar with 22 cases, 1.38 micromolar with 24 cases, 2.48 micromolar with 24 cases, 4.4 micromolar with 24 cases, and 7.86 micromolar with 23 cases; and Perfluorohexanesulfonic acid (micromolar), including 0.4 percent Dimethyl sulfoxide with 46 cases, 44.8 micromolar with 24 cases, 80 micromolar with 23 cases, 120 micromolar with 24 cases, 133.2 micromolar with 23 cases, 146.4 micromolar with 21 cases, and 160 micromolar with 24 cases.
Figure 2.
Locomotor activity assessment in 5-dpf zebrafish acutely exposed to PFOS or PFHxS. Locomotor response following acute exposure to (A) 7.86μM PFOS (blue), (D) 146.4μM PFHxS (green), or 0.4% DMSO (gray) in the light–dark transition test. Data expressed as the mean distance moved (cm/s) + standard error and represent 21–47 larvae per group. (B,E) Distance moved (cm) for each larva in 2-min periods across each 10-min light phase at 13,238 lux (L1, L2) and dark phase at 0 lux (D1, D2). Data are represented as box and violin plots comprising five values per larva in L1, L2, D1, D2. Violins around the box plots describe the kernel probability density of the underlying data. Significance was determined by Tukey-adjusted estimated marginal means following a generalized additive mixed effects model. Significant differences (p<0.05) between groups are indicated by different letters. VSR data [within 3 s after dark–light (VSR1) or light–dark transition (VSR2)] following acute exposure to (C) 0.437.86μM PFOS, or (F) 44.8160μM PFHxS are also shown. Data are represented as box and violin plots that comprise 1 value per larva for VSR1 and VSR2. Significance was determined by Tukey-adjusted estimated marginal means following a linear mixed effects model. Significant differences (p<0.05) between groups are indicated by different letters. Individual box plots comprise a box that describes the IQR, a bold line that represents the median, and whiskers that indicate the calculated minimum (25th percentile 1.5× IQR) and the calculated maximum (75th percentile +1.5× IQR). Dots represent outliers beyond the calculated minima or maxima. Violins around the box plots describe the kernel probability density of the underlying data. Replicate numbers tested for PFOS ranged from 23 to 47 larvae (C) and from 21 to 46 larvae for PFHxS (F). Summary data can be found in Excel Tables S5–S8. Note: D, dark; DMSO, dimethyl sulfoxide; dpf, days postfertilization; IQR, interquartile range; L, light; PFHxS, perfluorohexanesulfonic acid; PFOS, perfluorooctanesulfonic acid; VSR, visual startle response.
Figure 3A is an illustration of the washout study. The fertilized embryo was exposed to Perfluorooctanesulfonic acid or Perfluorohexanesulfonic acid on the first day postfertilization. The chemical washout happened on the fourth day after fertilization. During the fifth to seventh days post-fertilization, media was changed and larvae were fed and tested for developmental neurotoxicity (DNT) in the light-dark tansition assay. Eight days post-fertilization, media was changed and the larvae were tested for developmental neurotoxicity. Figure 3B is a set of four violin plots titled the D 1 phase, plotting Summed distance moved (centimeters per 2 minutes), ranging from 0 to 80 in increments of 20 (y-axis) across Perfluorooctanesulfonic acid (micromolar), ranging from 0.4 percent Dimethyl sulfoxide, 2.48 to 4.4 in increments of 1.92, 4.4 to 7.86 in increments of 3.46 (x-axis) measured at 5 days post-fertilization, 6 days post-fertilization, 7 days post-fertilization, and 8 days post-fertilization. Figure 3C is a set of four violin plots titled VSR2, plotting Summed distance moved (centimeters per 3 seconds), ranging from 0 to 5 in unit increments (y-axis) across Perfluorooctanesulfonic acid (micromolar), ranging from 0.4 percent Dimethyl sulfoxide, 2.48 to 4.4 in increments of 1.92, 4.4 to 7.86 in increments of 3.46 (x-axis). Data is shown in Figures 3B and 3C for 0.4 percent Dimethyl sulfoxide with 43 cases, 2.48 micromolar with 37 cases, 4.4 micromolar with 36 cases, and 7.86 micromolar with 23 cases at 5 days post-fertilization; 0.4 percent Dimethyl sulfoxide with 43 cases, 2.48 micromolar with 42 cases, 4.4 micromolar with 40 cases, and 7.86 micromolar with 32 cases at 6 days post-fertilization; 0.4 percent Dimethyl sulfoxide with 43 cases, 2.48 micromolar with 40 cases, 4.4 micromolar with 38 cases, and 7.86 micromolar with 30 cases at 7 days post-fertilization; and 0.4 percent Dimethyl sulfoxide with 43 cases, 2.48 micromolar with 39 cases, 4.4 micromolar with 34 cases, and 7.86 micromolar with 23 cases at 8 days post-fertilization. Figure 3D is a set of four violin plots titled the D 2  phase, plotting Summed distance moved (centimeters per 2 minutes), ranging from 0 to 80 in increments of 20 (y-axis) across Perfluorohexanesulfonic acid (micromolar), ranging from 0.4 percent Dimethyl sulfoxide, 44.8 to 80 in increments of 35.2, and 80 to 120 in increments of 40 (x-axis). Figure 3E is a set of four violin plots titled VSR2, plotting Summed distance moved (centimeters per 3 seconds), ranging from 0 to 5 in unit increments (y-axis) across Perfluorohexanesulfonic acid (micromolar), ranging from 0.4 percent Dimethyl sulfoxide, 44.8 to 80 in increments of 35.2, and 80 to 120 in increments of 40 (x-axis). Data is shown in Figure 3D and 3E for 0.4 percent Dimethyl sulfoxide with 48 cases, 44.8 micromolar with 46 cases, 80 micromolar with 44 cases, and 120 micromolar with 38 cases at 5 days post-fertilization; 0.4 percent Dimethyl sulfoxide with 47 cases, 44.8 micromolar with 48 cases, 80 micromolar with 45 cases, and 120 micromolar with 40 cases at 5 days post-fertilization; 0.4 percent Dimethyl sulfoxide with 47 cases, 44.8 micromolar with 47 cases, 80 micromolar with 45 cases, and 120 micromolar with 41 cases at 5 days post-fertilization; and 0.4 percent Dimethyl sulfoxide with 45 cases, 44.8 micromolar with 46 cases, 80 micromolar with 44 cases, and 120 micromolar with 39 cases at 5 days post-fertilization.
Figure 3.
Washout study to characterize persistence of PFOS- or PFHxS-dependent dark-phase and VSR hyperactivity. (A) Experimental design of the washout study. (B,D) Distance moved (cm) for each larva in 2-min periods across each 10-min light phase at 13,238 lux (L1, L2) and dark phase at 0 lux (D1, D2) for behavior tests at 5–8 dpf. Data are represented as box and violin plots comprising 5 values per larva in the D1 phase. Violins around the box plots describe the kernel probability density of the underlying data. Significance was determined by Tukey-adjusted estimated marginal means following a generalized additive mixed effects model. Significant differences (p<0.05) between groups are indicated by different letters. VSR data within 3 s after light–dark transition (VSR2) following developmental exposure to (C) 2.487.86μM PFOS, or (E) 44.8120μM PFHxS are also shown for behavior tests at 5–8 dpf. Data are represented as box and violin plots that comprise 1 value per larva. Significance was determined by Tukey-adjusted estimated marginal means following a linear mixed effects model. Significant differences (p<0.05) between groups are indicated by different letters. Individual box plots comprise a box that describes the IQR, a bold line that represents the median, and whiskers that indicate the calculated minimum (25th percentile 1.5× IQR) and the calculated maximum (75th percentile +1.5× IQR). Dots represent outliers beyond the calculated minima or maxima. Violins around the box plots describe the kernel probability density of the underlying data. Replicate numbers tested for PFOS ranged from 23 to 43 larvae (B,C) and from 38 to 48 larvae for PFHxS (D,E). Summary data can be found in Excel Tables S9–S12. Note: Chem, chemical; D, dark; DMSO, dimethyl sulfoxide; DNT, developmental neurotoxicity; dpf, days postfertilization; IQR, interquartile range; L, light; PFHxS, perfluorohexanesulfonic acid; PFOS, perfluorooctanesulfonic acid; VSR, visual startle response.
Figure 4A is an illustration of the RNA sequencing strategy. Step 1: On the day of fertilization, the embryos were treated with Perfluorooctanesulfonic acid and Perfluorohexanesulfonic acid. The embryos were exposed to chemicals at 26 degrees Celsius for five days. Head tissue samples of larval zebrafish were taken at four and 5 days postfertilization. Step 2: Differentially expressed genes in zebrafish were discovered by head ribonucleic acid sequencing. Step 3: ToxNodes, human differentially expressed genes, and transcriptomic benchmark concentrations were obtained from the differently expressed genes in zebrafish. Step 4: Shared toxnodes resulted in functional enrichment from toxnodes. Step 5: Pathway analysis was prompted by the differentially expressed genes, and this analysis identified upstream regulators.
Figure 4.
Experimental design for exploratory RNA-seq. Head dissections of PFOS (0.88μM, 1.57μM, 2.8μM) or PFHxS (7.87μM, 14μM, 25.1μM)-exposed larvae were conducted on 4–5 dpf for RNA-seq with five biological replicates per condition. Differentially expressed genes (DEGs) were used for functional enrichment analysis using ToxNodes in SOM-format, calculation of transcriptomic benchmark concentrations (BMCT), and upstream regulator predictions via an Ingenuity Pathway Analysis. Note: dpf, days postfertilization; PFHxS, perfluorohexanesulfonic acid; PFOS, perfluorooctanesulfonic acid; RNA-seq, RNA sequencing; SOM, self-organizing map.
Figure 5A is a SOM showing nodes that a significantly altered in zebrafish head tissue exposed to Perfluorooctanesulfonic acid. Figure 5B is a SOM showing nodes that a significantly altered in zebrafish head tissue exposed to Perfluorohexanesulfonic acid. Figure 5C is a SOM showing nodes that a significantly altered in zebrafish head tissue exposed to Perfluorooctanesulfonic acid plus Perfluorohexanesulfonic acid. A scale depicts the mean (log fold change) ranging from negative 2 to 2 in unit increments. Figure 5D is a dot plot titled Overrepresentation of the top 10 Gene Ontology pathways, plotting Positive regulation of nucleocytoplasmic transport, ribonucleic acid export from nucleus, regulation of DNA-templated transcription elongation, nuclear export, establishment of ribonucleic acid localization, ribonucleic acid transport, nucleic acid transport, ribonucleic acid localization, nuclear transport, nucleocytoplasmic transport, ribose phosphate biosynthetic process, ribonucleotide biosynthetic process, ribonucleoside triphosphate biosynthetic process, purine nucleoside triphosphate biosynthetic process, oxidative phosphorylation, purine ribonucleoside triphosphate biosynthetic process, proton motive force-driven ATP synthesis, proton motive force-driven mitochondrial ATP synthesis, nucleoside phosphate biosynthetic process, nucleotide biosynthetic process, monocarboxylic acid catabolic process, lipid oxidation, monosaccharide catabolic process, fatty acid oxidation, purine ribonucleotide metabolic process, fatty acid catabolic process, fatty acid beta-oxidation, organic acid catabolic process, carboxylic acid catabolic process, and small molecule catabolic process (y-axis) across walktrap 2 (47), walktrap 3 (224), and walktrap 4 (272) (x-axis) for Count, ranging from 20 to 5 in decrements of 5 and lowercase p adjusted, ranging from 0.000 to 0.100 in increments of 0.025. Figure 5E a dot plot titled Overrepresentation of the top 10 Kyoto Encyclopedia of Genes and Genomes pathways, plotting adherens junctions; Alzheimer disease; amyotrophic lateral sclerosis; chemical carcinogenesis–reactive oxygen species; citrate cycle (TCA cycle); colorectal cancer; diabetic cardiomyopathy; glycine, serine and threonine metabolism; hepatocellular carcinoma; Huntington disease; messenger ribonucleic acid surveillance pathway; nucleocytoplasmic transport; oxidative phosphorylation; Parkinson disease; pathways of neurodegeneration-multiple disease; prion disease; proteasome; protein processing in endoplasmic reticulum; Salmonella infection; signaling pathways regulating pluripotency of stem cells; spliceosome; thyroid cancer; and Wnt signaling pathway (y-axis) across walktrap 2 (33), walktrap 3 (122), and walktrap 4 (142) (x-axis) for Count, ranging from 20 to 5 in decrements of 5 and lowercase p adjusted, ranging from 0.00 to 0.05 in increments of 0.01.
Figure 5.
Global gene expression patterns and altered pathways in head tissue obtained from zebrafish developmentally exposed to PFOS or PFHxS. (A,B,C) Significantly enriched gene nodes at 5 dpf following exposure to (A) PFOS or (B) PFHxS, or (C) the combined dataset were projected onto a self-organizing map (SOM). Individual concentrations were combined for each substance and a single SOM was calculated with a treatment vs. control contrast. (See Figure S4 for 4-dpf SOMs.) Mean logarithmic fold changes (FCs) per node are shown. (D) Overrepresentation analysis of the top 10 Gene Ontology (GO) pathways based on differentially expressed genes (DEGs) identified for each functional group (i.e., walktrap) for the combined 5-dpf dataset. (E) Overrepresentation analysis of the top 10 KEGG pathways based on DEGs per walktrap. Numbers in brackets indicate the total number of genes assigned to each walktrap. The number of genes per pathway (count) and significance levels (p.adjust) are shown. Five biological replicates containing pools of 15 heads were used. RNA-seq data shown here can be found in Excel Tables S13–S18. Note: ATP, adenosine triphosphate; dpf, days postfertilization; GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; PFHxS, perfluorohexanesulfonic acid; PFOS, perfluorooctanesulfonic acid; RNA-seq, RNA sequencing; TCA, tricarboxylic acid.
Figure 6A is a heatmap, plotting Peroxisome proliferator-activated receptor alpha, Peroxisome proliferator-activated receptor delta, and Peroxisome proliferator-activated receptor gamma (y-axis) across 25.1 micromolar Perfluorohexanesulfonic acid, 7.87 micromolar Perfluorohexanesulfonic acid, 0.88 micromolar Perfluorooctanesulfonic acid under 4 days post-fertilization and 25.1 micromolar Perfluorohexanesulfonic acid, 7.87 micromolar Perfluorohexanesulfonic acid, 2.8 micromolar Perfluorooctanesulfonic acid, and 1.57 micromolar Perfluorooctanesulfonic acid under 5 days post-fertilization (x-axis) for lowercase p value, ranging from 0.00001 to 0.04001 in increments of 0.01. Figure 6B is a set of three rose diagrams titled Perfluorooctanesulfonic acid, Perfluorohexanesulfonic acid, ToxCast peroxisome proliferator-activated receptor assays, plotting Toxicological Priority Index score, ranging from 0.00 to 1.00 in increments of 0.25 (y-axis) across in vitro assays targeting human, rat, mouse, zebrafish (x-axis) for ATG frPPARa EcoTox2 up, ATG hPPARg XSP1 up, ATG zfPPARg XSP1 up, ATG hPPARa EcoTox2 dn, ATG hPPARg XSP2 dn, ATG zfPPARg XSP2 dn, ATG hPPARa EcoTox2 up, ATG hPPARg XSP2 up, ATG zfPPARg XSP2 up, ATG JmPPARa EcoTox2 up, ERFPL NR binding hPPARG up, ATG PPARg TRANS dn, ATG PPARa TRANS dn, NVS NR hPPARg, ATG PPARg TRANS up, ATG PPARa TRANS up, ATG mPPARg XSP1 dn, OT PPARg PPARgSRC1 0480, ATG rtPPARa EcoTox2 dn, ATG mPPARg XSP1 up, OT PPARg PPARgSRC1 1440, ATG rtPPARa EcoTox2 up, ATG mPPARg XSP2 dn, TOX21 PPARg BLA agonist ratio, ATG zfPPARa EcoTox2 up, ATG mPPARg XSP2 up, TOX21 PPARg BLA antagonist ratio, NVS NR hPPARa, ATG rtPPARg EcoTox2 dn, ATG PPARd TRANS dn, ATG JmPPARg EcoTox2 up, ATG rtPPARg EcoTox2 up, ATG PPARd TRANS up, ATG hPPARg EcoTox2 up, ATG zfPPARg EcoTox2 up, TOX21 PPARd BLA agonist ratio, ATG hPPARg XSP1 dn, ATG zfPPARg XSP1 dn, and TOX21 PPARd BLA antagonist ratio.
Figure 6.
Predicted upstream regulators affected by developmental exposure to PFOS or PFHxS and in vitro potency profiles. (A) Human orthologs for zebrafish differentially expressed genes (DEGs) were analyzed by Ingenuity Pathway Analysis and predicted human PPARα, PPARδ, and PPARγ as putative upstream regulators for multiple concentrations of PFOS and PFHxS at 4–5 dpf. Significant enrichment was identified by Fisher’s exact test p<0.05; crosses indicate nonsignificance. Five biological replicates containing pools of 15 heads were used. (B) Visualized potency profiles of PFOS and PFHxS in US EPA CompTox (version 3.5) in vitro assays targeting human (h), rat (r), mouse (m), zebrafish (zf), or Japanese medaka (jm) PPARα, PPARδ, and/or PPARγ. Profiles for both chemicals were calculated based on AC50-values using the ToxPi framework. Distance from the center indicates potency. All assays were weighted equally. ToxPi data can be found in Excel Table S19. Note: AC50, 50% activity concentration; dpf, days postfertilization; EPA, Environmental Protection Agency; PFHxS, perfluorohexanesulfonic acid; PFOS, perfluorooctanesulfonic acid; PPAR, peroxisome proliferator-activated receptor; ToxPi, toxicity prioritization index.
Figure 7A is an illustration of a Clustered Regularly Interspaced Short Palindromic Repeats, or Cas9-based gene that depicts the embryos that undergo gene knockdown, including set 1 or set 2 crispants, in comparison with the negative control. One day after fertilization, crispants that had not undergone gene knockdowns were subjected to Perfluorooctanesulfonic acid. At four days postfertilization, the chemical was removed, and at five days postfertilization, the behavior was evaluated. Within three seconds of the shift in the peroxisome proliferator-activated receptor gamma-knockdown larvae, there was a visual startle reaction 2. Figure 7B is a set of two violin plots titled 0.4 percent Dimethyl sulfoxide and 7.86 micromolar Perfluorooctanesulfonic acid, plotting Summed distance moved (centimeters per 3 seconds), ranging from 0 to 5 in unit increments (left y-axis) and Visual startle response 2 (right y-axis) across negative control crispants, set 1, and set 2 (x-axis) for peroxisome proliferator-activated receptor gamma-knockdown: 41, 28, and 34 cases in Dimethyl sulfoxide and 38, 28, and 24 cases in Perfluorooctanesulfonic acid. Figure 7C is a set of two violin plots titled 0.4 percent Dimethyl sulfoxide and 7.86 micromolar Perfluorooctanesulfonic acid, plotting Summed distance moved (centimeters per 3 seconds), ranging from 0 to 5 in unit increments (left y-axis) and Visual startle response 2 (right y-axis) across negative control crispants, set 3, and set 4 (x-axis) for peroxisome proliferator-activated receptor gamma-knockdown: 44, 42, and 31 cases in Dimethyl sulfoxide and 36, 38, and 35 cases in Perfluorooctanesulfonic acid. Figure 7D is a set of two violin plots titled 0.4 percent Dimethyl sulfoxide and 7.86 micromolar Perfluorooctanesulfonic acid, plotting Summed distance moved (centimeters per 3 seconds), ranging from 0 to 5 in unit increments (left y-axis) and Visual startle response 2 (right y-axis) across negative control crispants, set 5, and set 6 (x-axis) for peroxisome proliferator-activated receptor gamma-knockdown: 47, 12, and 23 cases in Dimethyl sulfoxide and 40, 11, and 10 cases in Perfluorooctanesulfonic acid. Figure 7E is a set of two violin plots titled 0.4 percent Dimethyl sulfoxide and 7.86 micromolar perfluorooctanesulfonic acid, plotting Summed distance moved (centimeters per 3 seconds), ranging from 0 to 5 in unit increments (left y-axis) and Visual startle response 2 (right y-axis) across negative control crispants, set 7, and set 8 (x-axis) for peroxisome proliferator-activated receptor gamma-knockdown: 74, 53, and 45 cases in Dimethyl sulfoxide and 72, 44, and 49 cases in Perfluorooctanesulfonic acid.
Figure 7.
Knockdown study to determine the essentiality of ppar genes for VSR hyperactivity in PFOS-exposed zebrafish. (A) CRISPR/Cas9-based gene editing experimental design were embryos that experience gene knockdown (set 1 or set 2 crispants) relative to negative control crispants (NC) that did not experience gene knockdown and were subsequently exposed to 7.86μM PFOS at 1 dpf. The chemical was removed at 4 dpf and behavior was assessed at 5 dpf. VSR within 3 s after light–dark transition (VSR2) in (B) pparg-knockdown, (C) pparaa/ab-knockdown, or (D,E) pparda/db-knockdown larvae exposed to 7.86μM PFOS are shown. Data are represented as box and violin plots and comprise 1 value per larva. Significance was determined by Tukey-adjusted estimated marginal means following a linear mixed effects model. Significant differences (p<0.05) between groups are indicated by different letters. Individual box plots comprise a box that describes the IQR, a bold line that represents the median, and whiskers that indicate the calculated minimum (25th percentile 1.5× IQR) and the calculated maximum (75th percentile +1.5× IQR). Dots represent outliers beyond the calculated minima or maxima. Violins around the box plots describe the kernel probability density of the underlying data. Replicate numbers were 24–41 for pparg-knockdown (B), 31–44 for pparaa/ab-knockdown (C), 10–47 for initial pparda/db-knockdown, and 44–75 for pparda/db-knockdown with revised guide sets. Summary data can be found in Excel Tables S20–S23. Note: CRISPR, Clustered Regularly Interspaced Short Palindromic Repeats; DNT, developmental neurotoxicity; dpf, days postfertilization; IQR, interquartile range; PFOS, perfluorooctanesulfonic acid; ppar, peroxisome proliferator-activated receptor; VSR, visual startle response.
Figure 8 is one violin plot and one table. The violin plot titled Visual startle response 2, plotting Summed distance moved (centimeters per 3 seconds), ranging from 0 to 5 in unit increments (y-axis) across Dimethyl sulfoxide with 4-Chloro-N-(2-{[5-trifluoromethyl)-2-pyridyl]sulfonyl}ethyl)benzamide, Perfluorooctanesulfonic acid with 4-Chloro-N-(2-{[5-trifluoromethyl)-2-pyridyl]sulfonyl}ethyl)benzamide, and Perfluorooctanesulfonic acid with 4-Chloro-N-(2-{[5-trifluoromethyl)-2-pyridyl]sulfonyl}ethyl)benzamide (x-axis). A tabular representation, in three columns, lists 4-Chloro-N-(2-{[5-trifluoromethyl)-2-pyridyl]sulfonyl}ethyl)benzamide, Perfluorooctanesulfonic acid (micromolar), and number of cases. Row 1: 0, 0, 55 cases. Row 2: 9.25, 0, and 28 cases. Row 3: 27.2, 0, and 29 cases. Row 4: 0, 7.86, and 49 cases. Row 5: 9.25, 7.86, and 33 cases. Row 6: 27.2, 7.86, and 19 cases. Row 7: 0, 11.72, and 33 cases. Row 8: 9.25, 11.72, and 18 cases. Row 9: 27.2, 11.72, and 16 cases.
Figure 8.
Coexposure of pparda/db-antagonist GSK3787 and PFOS. To mimic the CRISPR study design, embryos were exposed to 9.25 or 27.2μM of the ppard antagonist GSK3787 or 0.4% DMSO at 0 dpf. At 1 dpf, embryos were exposed to 7.86 or 11.72μM PFOS or DMSO, the chemical was removed at 4 dpf, and behavior was assessed at 5 dpf. Data shown for VSR within 3 s after light–dark transition (VSR2) are represented as box and violin plots and comprise 1 value per larva. Significance was determined by Tukey-adjusted estimated marginal means following a linear mixed effects model. Significant differences (p<0.05) between groups are indicated by different letters. Individual box plots comprise a box that describes the IQR, a bold line that represents the median, and whiskers that indicate the calculated minimum (25th percentile 1.5× IQR) and the calculated maximum (75th percentile +1.5× IQR). Dots represent outliers beyond the calculated minima or maxima. Violins around the box plots describe the kernel probability density of the underlying data. Replicate numbers ranged from 16 to 55 larvae. Summary data can be found in Excel Table S24. Note: CRISPR, Clustered Regularly Interspaced Short Palindromic Repeats; DMSO, dimethyl sulfoxide; dpf, days postfertilization; GSK3787, ppard antagonist; IQR, interquartile range; PFOS, perfluorooctanesulfonic acid; VSR, visual startle response.

References

    1. Williams AJ, Gaines LGT, Grulke CM, Lowe CN, Sinclair GFB, Samano V, et al. . 2022. Assembly and curation of lists of per- and polyfluoroalkyl substances (PFAS) to support environmental science research. Front Environ Sci 10:1–13, PMID: 35936994, 10.3389/fenvs.2022.850019. - DOI - PMC - PubMed
    1. Banks RE, Smart BE, Tatlow J. 2013. Organofluorine Chemistry: Principles and Commercial Applications. New York, NY: Springer Science & Business Media.
    1. Kissa E. 2001. Fluorinated Surfactants and Repellents. 2nd ed. New York, NY: Marcel Dekker.
    1. Lindstrom AB, Strynar MJ, Libelo EL. 2011. Polyfluorinated compounds: past, present, and future. Environ Sci Technol 45(19):7954–7961, PMID: 21866930, 10.1021/es2011622. - DOI - PubMed
    1. Schultz MM, Barofsky DF, Field JA. 2003. Fluorinated alkyl surfactants. Environ Eng Sci 20(5):487–501, 10.1089/109287503768335959. - DOI

MeSH terms

LinkOut - more resources